已收盘 09-20 16:00:00 美东时间
-0.030
-1.71%
On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' shareholders, based on an exchange ratio valuing Cyclo Therapeutics shares at $.95 per share and Rafael Holdings at its cash value
08-22 18:52
12:03 PM EDT, 05/24/2022 (MT Newswires) -- Rafael Holdings' (RFL) Cornerstone P...
2022-05-25 00:04
Cranbury, NJ, May 24, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc...
2022-05-24 23:05
Company name change reflects mission to address significant unmet needs in rare...
2022-05-19 21:09
北京时间2022年04月26日01时26分,Rafael Holdings Inc(RFL.us)股票出现异动,股价大幅上涨5.19%。截至发稿,该股报2.2...
2022-04-26 02:47
Earnings Flash (RFL) RAFAEL HOLDINGS Posts Q2 Revenue $1.1M
2022-03-18 04:06
NEW YORK, March 2, 2022 /PRNewswire/ -- PomerantzLLP is investigating claims on...
2022-03-03 11:56
04:13 AM EST, 02/16/2022 (MT Newswires) -- Rafael Holdings (RFL) filed for a se...
2022-02-16 17:16
11:51 AM EST, 01/18/2022 (MT Newswires) -- Rafael Pharmaceuticals (RFL) said Tu...
2022-01-19 00:56
Oct 18 (Reuters) - Rafael Holdings Inc RFL.N : * RAFAEL HOLDINGS REPORTS FOURTH...
2021-10-19 04:41